Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

5.66
Delayed Data
As of Sep 01
 -0.24 / -4.07%
Today’s Change
2.98
Today|||52-Week Range
8.59
+19.66%
Year-to-Date

Today’s Trading

Previous close5.90
Today’s open5.76
Day’s range5.66 - 5.91
Volume2,304,907
Average volume (3 months)1,707,752
Market cap$838.8M
Dividend yield--
Data as of 3:59pm ET, 09/01/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-914.29%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+23.36%
P/E ratio85.6
Price/Sales19.68
Price/Book19.66

Competitors

 Today’s
change
Today’s
% change
EPZMEpizyme Inc-0.37-1.85%
SUPNSupernus Pharmaceuti...+0.68+3.75%
SGYPSynergy Pharmaceutic...-0.18-2.57%
FLMLFlamel Technologies ...-0.19-0.86%
Data as of 3:59pm ET, 09/01/2015

Financials

Next reporting dateNovember 2, 2015
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$51.9M
Annual profit (last year)$9.4M
Net profit margin18.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts

Partner Offers